Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
19.20
+0.13 (0.68%)
Nov 6, 2026, 4:00 PM EST - Market closed
Healthcare Realty Trust Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 1,090 | 1,138 | 1,233 | 1,309 | 907.45 | 520.33 |
Other Revenue | 35.22 | 28.03 | 19.02 | 15.77 | 13.02 | 9.5 |
| 1,137 | 1,180 | 1,268 | 1,342 | 931.95 | 534.02 | |
Revenue Growth (YoY | -5.59% | -6.93% | -5.51% | 44.01% | 74.52% | 7.05% |
Property Expenses | 433.21 | 451.1 | 476.57 | 502.46 | 347.27 | 216.2 |
Selling, General & Administrative | 57.93 | 72.57 | 83.12 | 58.41 | 52.73 | 34.15 |
Depreciation & Amortization | 495.97 | 563.97 | 675.15 | 730.71 | 453.08 | 202.71 |
Total Operating Expenses | 987.11 | 1,088 | 1,235 | 1,292 | 853.08 | 453.07 |
Operating Income | 150.28 | 92.72 | 33.34 | 50.51 | 78.87 | 80.95 |
Interest Expense | -183.67 | -213.29 | -242.69 | -258.58 | -148.24 | -53.13 |
Interest & Investment Income | - | - | - | 1.34 | - | - |
Other Non-Operating Income | 1.11 | 0.75 | - | - | - | - |
EBT Excluding Unusual Items | -32.27 | -119.83 | -209.34 | -206.73 | -69.37 | 27.82 |
Merger & Restructuring Charges | - | - | - | 1.95 | -103.38 | - |
Impairment of Goodwill | - | - | -250.53 | - | - | - |
Gain (Loss) on Sale of Assets | 152.68 | 235.39 | 109.75 | 77.55 | 270.27 | 55.94 |
Asset Writedown | -165.12 | -364.6 | -313.55 | -154.91 | -54.43 | -17.1 |
Other Unusual Items | -2.38 | -0.45 | -0.24 | 0.06 | -2.4 | - |
Pretax Income | -45.2 | -249.49 | -663.9 | -282.08 | 40.69 | 66.66 |
Earnings From Continuing Operations | -45.2 | -249.49 | -663.9 | -282.08 | 40.69 | 66.66 |
Net Income to Company | -45.2 | -249.49 | -663.9 | -282.08 | 40.69 | 66.66 |
Minority Interest in Earnings | 0.26 | 3.41 | 9.42 | 3.82 | 0.2 | - |
Net Income | -44.93 | -246.07 | -654.49 | -278.26 | 40.9 | 66.66 |
Preferred Dividends & Other Adjustments | 2.45 | 2.41 | 5.92 | 3.36 | 2.44 | 2.15 |
Net Income to Common | -47.38 | -248.48 | -660.41 | -281.62 | 38.46 | 64.51 |
Net Income Growth | - | - | - | - | -40.38% | -8.00% |
Basic Shares Outstanding | 345 | 350 | 366 | 379 | 252 | 143 |
Diluted Shares Outstanding | 345 | 350 | 366 | 379 | 254 | 143 |
Shares Change | -1.45% | -4.31% | -3.53% | 49.26% | 77.89% | 6.49% |
EPS (Basic) | -0.14 | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 |
EPS (Diluted) | -0.14 | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 |
EPS Growth | - | - | - | - | -66.26% | -13.46% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 0.960 | 1.030 | 1.240 | 1.240 | 0.729 | 1.218 |
Dividend Growth | -12.73% | -16.93% | 0% | 70.10% | -40.12% | 1.25% |
Operating Margin | 13.21% | 7.85% | 2.63% | 3.76% | 8.46% | 15.16% |
Profit Margin | -4.17% | -21.05% | -52.08% | -20.98% | 4.13% | 12.08% |
EBITDA | 708.84 | 703.89 | 755.66 | 826.4 | 556.64 | 287.46 |
EBITDA Margin | 62.32% | 59.63% | 59.59% | 61.58% | 59.73% | 53.83% |
D&A For Ebitda | 558.56 | 611.17 | 722.32 | 775.89 | 477.78 | 206.51 |
EBIT | 150.28 | 92.72 | 33.34 | 50.51 | 78.87 | 80.95 |
EBIT Margin | 13.21% | 7.85% | 2.63% | 3.76% | 8.46% | 15.16% |
Funds From Operations (FFO) | 508.49 | 490.05 | 193.26 | 547.13 | 296.98 | 241.52 |
FFO Per Share | 1.45 | 1.38 | 0.52 | 1.43 | 1.17 | 1.68 |
Adjusted Funds From Operations (AFFO) | 393.46 | 387.67 | 50.59 | 414.63 | 222.53 | 201.51 |
AFFO Per Share | 1.13 | 1.09 | 0.14 | 1.08 | 0.87 | 1.40 |
FFO Payout Ratio | 65.45% | 78.96% | 236.91% | 86.31% | 95.53% | 72.65% |
Revenue as Reported | 1,134 | 1,181 | 1,268 | 1,344 | 932.64 | 534.82 |